Quantedge Capital’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
SM
DCM
Quantedge Capital's ACLS Position: Q3 2022 in Review
Quantedge Capital sold out of Axcelis (ACLS) in Q3 2022, closing a stake of 33,700 shares — an estimated $1.85M sold.
Quantedge Capital first reported a position in ACLS in Q1 2022 and held it in 2 quarters. The position peaked at $1.85M in Q2 2022. 287 funds tracked by Wall St. Rank hold ACLS as of Q3 2022.
- Quantedge Capital reported no remaining Axcelis position as of Q3 2022 after selling out during the quarter.
- Quantedge Capital sold 33,700 Axcelis shares in Q3 2022, an estimated $1.85M.
- Quantedge Capital first reported a position in Axcelis in Q1 2022 and held it in 2 quarters.
- Quantedge Capital's Axcelis position peaked at $1.85M in Q2 2022.
- 287 funds tracked by Wall St. Rank held Axcelis as of Q3 2022.
Based on Quantedge Capital's 13F filing for Q3 2022, filed 10 Nov 2022.